Shares of Medtronic (NYSE:MDT) reached a session low on Tuesday after the U.S. Food and Drug Administration (FDA) announced a product recall involving the company’s Pipeline Vantage 027 embolization ...
The U.S. FDA has posted several class I recalls in recent days, including a removal of one model of the Medtronic Vascular’s Pipeline Vantage embolization device due to insufficient apposition to the ...
This voluntary recall is being conducted due to the potential separation and detachment of the polytetrafluoroethylene (PTFE) coating on parts of these devices. Should the PTFE separate from the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results